Labcorp Holdings (LH) is drawing attention after its Plasma Detect assay was featured in two respected medical journals. The company’s digital pathology joint initiative with Lunit also made headlines ...
Global STD Diagnostics Market OverviewThe global STD diagnostics market is on a steady upward trajectory, projected to grow at a CAGR of 7–8% during the forecast period. This expansion is supported by ...
Lunit and Labcorp recently announced a collaboration to advance innovation in digital pathology and artificial intelligence for oncology research, leveraging Labcorp's clinical and pathology expertise ...
Sandoz announced that Tyruko (natalizumab-sztn), a biosimilar of Biogen Idec’s Tysabri, is available to patients in the ...
Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...
Boston startup Bystro AI believes the mail-in genetic tests used by millions to trace their ancestry could also help people ...
Numerous companies offer tests, which may involve blood, urine or saliva collection, and can be very expensive. The results may not be accurate or useful.
The launch of Sandoz's Tyruko biosimilar of Tysabri (natalizumab) comes two years after the product was approved by the FDA, ...
Indianapolis-based Roche Diagnostics said while the survey was conducted in Europe, its implications are global and reflect ...
Quest Diagnostics DGX invests in advanced diagnostics to deliver and scale innovative services that improve patient care and ...
Exact Sciences Corporation (EXAS) Presents at Jefferies London Healthcare Conference 2025 Transcript
Jefferies London Healthcare Conference 2025 November 18, 2025 7:30 AM ESTCompany ParticipantsKevin Conroy - Chairman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results